Need professional-grade analysis? Visit stockanalysis.com
$79.70M
12.94
211
N/A
Eurofins-Cerep SA (ALECR) trades on Euronext Paris in EUR. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at EUR15800.00.
Over the past year, ALECR has traded between a low of EUR15400.00 and a high of EUR18900.00. The stock has lost 16.4% over this period. It is currently 16.4% below its 52-week high.
Eurofins-Cerep SA has a market capitalization of $79.70M, with a price-to-earnings ratio of 12.94.
Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company's research services include compound management, and high-throughput screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and is based in Celle-Lévescault, France. Eurofins-Cerep SA is a subsidiary of Eurofins Discovery Services LUX Holding SARL.
Side-by-side comparison against top Healthcare peers.